Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Matti Annala
Based on 20 articles published since 2009
(Why 20 articles?)
||||
Expertise Level
The expertise of Matti Annala ranks in the
  • Top 2.4%
  • ... of 132,850 published authors worldwide on Prostatic Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    University of Tampere      
2019
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. Electronic address: · Pubmed 30638634
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Faculty of Medicine and Life Sciences and Biomeditech Institute, University of Tampere, Tampere, Finland. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Southern Interior Centre, Kelowna, British Columbia, Canada. · British Columbia Cancer Agency, Fraser Valley Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada. · British Columbia Cancer Agency, Abbotsford Centre, Vancouver, British Columbia, Canada. · Monash University, Monash, Australia. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 29367197
  • Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. · Department of Urology, University of Tampere, Tampere University Hospital, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Departments of Surgery (Urology), Laboratory Medicine and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Department of Translational Medicine, Lund University, Malmö, Sweden. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Pubmed 29988112
  • Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, 33014, Finland. · FimLab Laboratories, Tampere University Hospital, Tampere, 33101, Finland. · Department of Ophthalmology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, 33014, Finland. · Department of Urology, University of Tampere and Tampere University Hospital, Tampere, 33521, Finland. · Singapore Eye Research Institute, Singapore, 169856, Singapore. · Duke-NUS Neuroscience, Singapore, 169857, Singapore. · Duke-NUS Medical School Ophthalmology and Visual Sciences Academic Clinical Program, Singapore, 169857, Singapore. · Ophthalmology, Yong Loo Lin Medical School, National University of Singapore, Singapore, 119228, Singapore. · Tays Eye Centre, Tampere University Hospital, Tampere, 33521, Finland. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, 33014, Finland. · Science Center, Tampere University Hospital, Tampere, 33521, Finland. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, 33014, Finland. · FimLab Laboratories, Tampere University Hospital, Tampere, 33101, Finland. · Pubmed 29563510
2017
  • BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forksningsparken, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA. · Pubmed 29269934
  • Division of Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, New York. · Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, New York. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York New York. · Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York. · Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, New York. · Alliance Statistics and Data Center and Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina. · Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 28842510
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
2016
  • Prostate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere, Tampere, Finland. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Pathology, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Prostate Cancer Research Center, School of Medicine, University of Tampere, Tampere, Finland. · Department of Urology, Tampere University Hospital, Tampere, Finland. · Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan Kettering Cancer Center, New York, United States of America. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom. · Department of Translational Medicine, Lund University, Malmö, Sweden. · Pubmed 26939004
2015
  • Department of Signal Processing, Tampere University of Technology, Tampere, Finland. Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. · Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Department of Urology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. · Pubmed 26282172
  • Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 26129688
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Human Genetics, KU Leuven, Herestraat 49 Box 602, B-3000 Leuven, Belgium. · Cancer Research UK London Research Institute, London, UK. · Norwich Medical School and Department of Biological Sciences, University of East Anglia, Norwich, UK. · Institute of Biosciences and Medical Technology, BioMediTech, University of Tampere and Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA. · Laboratory of Pathology, National Cancer Institute, National Institutes of Health, MD, USA. · University of Liverpool and HCA Pathology Laboratories, London, UK. · Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project. · Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Uro-oncology Research Group, Cancer Research UK Cambridge Research Institute, Cambridge, UK. · Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Pubmed 25830880
  • Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland. · Institute of Biosciences and Medical Technology - BioMediTech, Tampere University of Technology, Tampere, Finland. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Urology, University of Washington, Seattle, WA, USA. · Department of Urology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 25749039
2014
  • 1] Biocenter Oulu, University of Oulu, Oulu, Finland. [2] Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland. [3]. · 1] Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. [2] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. [3]. · 1] Biocenter Oulu, University of Oulu, Oulu, Finland. [2] Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. · Department of Pathology, Oulu University Hospital, Oulu, Finland. · Prostate Cancer Research Center, Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. · Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden. · 1] Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. [2] Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland. · 1] Department of Pathology, Oulu University Hospital, Oulu, Finland. [2] Medical Research Center, University of Oulu, Oulu, Finland. · Pubmed 24390282
  • Institute of Biosciences and Medical Technology, Tampere, Finland Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 25006183
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
  • Prostate Cancer Research Center, Institute of Biosciences and Medical Technology-BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 25731699
Probable:    University of British Columbia      
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Faculty of Medicine and Life Sciences and Biomeditech Institute, University of Tampere, Tampere, Finland. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Southern Interior Centre, Kelowna, British Columbia, Canada. · British Columbia Cancer Agency, Fraser Valley Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada. · British Columbia Cancer Agency, Abbotsford Centre, Vancouver, British Columbia, Canada. · Monash University, Monash, Australia. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 29367197
2017
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
2016
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 26797585
2018
  • Department of Mechanical Engineering, University of British Columbia, Canada. · Pubmed 29762619
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
Probable:    Miscellaneous institutions in Tampere      
2016
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3School of Clinical Sciences, Monash University, Melbourne, Australia. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 27148695
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by Matti Annala about Prostatic Neoplasms:

  • Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer. 2019
  • Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer. 2018
  • Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases. 2018
  • Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissection. 2018
  • Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression. 2018
  • The expression of AURKA is androgen regulated in castration-resistant prostate cancer. 2017
  • Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. 2017
  • Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy. 2017
  • Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of 2017
  • Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer. 2017
Show List of Full Article Records
Google Searches

Learn more about Matti Annala using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Tampere
University of British Columbia
Miscellaneous institutions in Tampere
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Tampere
2019
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. Electronic address: · Pubmed 30638634
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Faculty of Medicine and Life Sciences and Biomeditech Institute, University of Tampere, Tampere, Finland. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Southern Interior Centre, Kelowna, British Columbia, Canada. · British Columbia Cancer Agency, Fraser Valley Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada. · British Columbia Cancer Agency, Abbotsford Centre, Vancouver, British Columbia, Canada. · Monash University, Monash, Australia. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 29367197
  • Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland. · Department of Urology, University of Tampere, Tampere University Hospital, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. · Departments of Surgery (Urology), Laboratory Medicine and Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. · Department of Translational Medicine, Lund University, Malmö, Sweden. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Pubmed 29988112
  • Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, 33014, Finland. · FimLab Laboratories, Tampere University Hospital, Tampere, 33101, Finland. · Department of Ophthalmology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, 33014, Finland. · Department of Urology, University of Tampere and Tampere University Hospital, Tampere, 33521, Finland. · Singapore Eye Research Institute, Singapore, 169856, Singapore. · Duke-NUS Neuroscience, Singapore, 169857, Singapore. · Duke-NUS Medical School Ophthalmology and Visual Sciences Academic Clinical Program, Singapore, 169857, Singapore. · Ophthalmology, Yong Loo Lin Medical School, National University of Singapore, Singapore, 119228, Singapore. · Tays Eye Centre, Tampere University Hospital, Tampere, 33521, Finland. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, 33014, Finland. · Science Center, Tampere University Hospital, Tampere, 33521, Finland. · Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, 33014, Finland. · FimLab Laboratories, Tampere University Hospital, Tampere, 33101, Finland. · Pubmed 29563510
2017
  • BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · BioMediTech Institute, Faculty of Medicine and Life Sciences, University of Tampere, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Centre for Molecular Medicine Norway, Nordic European Molecular Biology Laboratory Partnership, Forksningsparken, University of Oslo, Oslo, Norway. · Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Inflammation Research Centre, University of Oslo, Oslo, Norway. · Department of Urology, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, 21287, USA. · Pubmed 29269934
  • Division of Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, New York. · Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Division of Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, New York. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts. · Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York New York. · Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York. · Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, New York. · Alliance Statistics and Data Center and Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina. · Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 28842510
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
2016
  • Prostate Cancer Research Center, Institute of Biosciences and Medical Technology (BioMediTech), University of Tampere, Tampere, Finland. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Pathology, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Prostate Cancer Research Center, School of Medicine, University of Tampere, Tampere, Finland. · Department of Urology, Tampere University Hospital, Tampere, Finland. · Departments of Laboratory Medicine, Surgery, and Medicine, Memorial Sloan Kettering Cancer Center, New York, United States of America. · Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom. · Department of Translational Medicine, Lund University, Malmö, Sweden. · Pubmed 26939004
2015
  • Department of Signal Processing, Tampere University of Technology, Tampere, Finland. Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. · Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Department of Urology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Signal Processing, Tampere University of Technology, Tampere, Finland. Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland. · Pubmed 26282172
  • Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 26129688
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · Department of Human Genetics, KU Leuven, Herestraat 49 Box 602, B-3000 Leuven, Belgium. · Cancer Research UK London Research Institute, London, UK. · Norwich Medical School and Department of Biological Sciences, University of East Anglia, Norwich, UK. · Institute of Biosciences and Medical Technology, BioMediTech, University of Tampere and Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA. · Laboratory of Pathology, National Cancer Institute, National Institutes of Health, MD, USA. · University of Liverpool and HCA Pathology Laboratories, London, UK. · Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project. · Division of Genetics and Epidemiology, The Institute Of Cancer Research, London, UK. · Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. · Uro-oncology Research Group, Cancer Research UK Cambridge Research Institute, Cambridge, UK. · Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Royal Marsden NHS Foundation Trust, London and Sutton, UK. · Pubmed 25830880
  • Institute of Biosciences and Medical Technology - BioMediTech, University of Tampere, Tampere, Finland. · Institute of Biosciences and Medical Technology - BioMediTech, Tampere University of Technology, Tampere, Finland. · Fimlab Laboratories, Tampere University Hospital, Tampere, Finland. · Department of Urology, University of Washington, Seattle, WA, USA. · Department of Urology, Tampere University Hospital and Medical School, University of Tampere, Tampere, Finland. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 25749039
2014
  • 1] Biocenter Oulu, University of Oulu, Oulu, Finland. [2] Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland. [3]. · 1] Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. [2] Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. [3]. · 1] Biocenter Oulu, University of Oulu, Oulu, Finland. [2] Department of Medical Biochemistry and Molecular Biology, Institute of Biomedicine, University of Oulu, Oulu, Finland. · Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. · Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China. · Department of Pathology, Oulu University Hospital, Oulu, Finland. · Prostate Cancer Research Center, Institute of Biomedical Technology and BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. · Department of Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden. · 1] Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. [2] Genome-Scale Biology Program, University of Helsinki, Helsinki, Finland. · 1] Department of Pathology, Oulu University Hospital, Oulu, Finland. [2] Medical Research Center, University of Oulu, Oulu, Finland. · Pubmed 24390282
  • Institute of Biosciences and Medical Technology, Tampere, Finland Department of Signal Processing, Tampere University of Technology, Tampere, Finland. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 25006183
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
  • Prostate Cancer Research Center, Institute of Biosciences and Medical Technology-BioMediTech and Fimlab Laboratories, University of Tampere and Tampere University Hospital, Tampere, Finland. · Pubmed 25731699
University of British Columbia
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Faculty of Medicine and Life Sciences and Biomeditech Institute, University of Tampere, Tampere, Finland. · British Columbia Cancer Agency, Vancouver Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Southern Interior Centre, Kelowna, British Columbia, Canada. · British Columbia Cancer Agency, Fraser Valley Centre, Vancouver, British Columbia, Canada. · British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada. · British Columbia Cancer Agency, Abbotsford Centre, Vancouver, British Columbia, Canada. · Monash University, Monash, Australia. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 29367197
2017
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Epidemiology and Biostatistics, UCSF, San Francisco, California. · Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon. · Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, Oregon. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Radiation Oncology, UCSF, San Francisco, California. · Division of Hematology and Oncology, UCSF, San Francisco, California. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Department of Laboratory Medicine, University of Washington, Seattle, Washington. · Department of Pathology, Oregon Health & Science University, Portland, Oregon. · Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The CRUK Gene Function Laboratory and Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California. · Department of Medicine, UCSF, San Francisco, California. · Pubmed 28450426
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
2016
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 26797585
2018
  • Department of Mechanical Engineering, University of British Columbia, Canada. · Pubmed 29762619
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
Miscellaneous institutions in Tampere
2016
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3School of Clinical Sciences, Monash University, Melbourne, Australia. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 27148695
5 Other Locations Show
Yearly article counts 14535200000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.